Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Subtil

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Human Hypertension|April 18, 2014
Can we identify response markers to antihypertensive drugs? First results from the IDEAL TrialF Gueyffier, F Subtil, T Bejan-Angoulvant, et al.
Annales Pharmaceutiques Francaises|November 24, 2023
ANTIFON-CLIC®, a new clinical decision support system for the treatment of invasive aspergillosis: is it clinically relevant?A-L Bienvenu, V Leray, C Guichon, et al.
Trials|March 13, 2021
Determination of the optimal dose of ephedrine in the treatment of arterial hypotension due to general anesthesia in neonates and infants below 6 months old: the ephedrine study protocol for a randomized, open-label, controlled, dose escalation trialA S Szostek, P Boucher, F Subtil, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Human Hypertension|April 18, 2014
Can we identify response markers to antihypertensive drugs? First results from the IDEAL TrialF Gueyffier, F Subtil, T Bejan-Angoulvant, et al.
Annales Pharmaceutiques Francaises|November 24, 2023
ANTIFON-CLIC®, a new clinical decision support system for the treatment of invasive aspergillosis: is it clinically relevant?A-L Bienvenu, V Leray, C Guichon, et al.
Trials|March 13, 2021
Determination of the optimal dose of ephedrine in the treatment of arterial hypotension due to general anesthesia in neonates and infants below 6 months old: the ephedrine study protocol for a randomized, open-label, controlled, dose escalation trialA S Szostek, P Boucher, F Subtil, et al.
Pageof 2